REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 138 filers reported holding REPLIMUNE GROUP INC in Q1 2023. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,470,450 | -7.7% | 261,277 | +25.2% | 0.00% | 0.0% |
Q2 2023 | $4,844,713 | +89.0% | 208,644 | +43.7% | 0.00% | 0.0% |
Q1 2023 | $2,563,278 | -66.9% | 145,146 | -48.9% | 0.00% | -50.0% |
Q4 2022 | $7,733,096 | +1592.1% | 284,305 | +974.3% | 0.00% | – |
Q3 2022 | $457,000 | -41.6% | 26,463 | -40.9% | 0.00% | – |
Q2 2022 | $782,000 | +2.9% | 44,759 | 0.0% | 0.00% | – |
Q1 2022 | $760,000 | -88.6% | 44,759 | -81.7% | 0.00% | -100.0% |
Q4 2021 | $6,646,000 | -38.7% | 245,251 | -33.0% | 0.00% | -50.0% |
Q3 2021 | $10,849,000 | -23.0% | 366,009 | -0.1% | 0.00% | 0.0% |
Q2 2021 | $14,081,000 | – | 366,502 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 5,344,971 | $122,395,000 | 33.11% |
Corriente Advisors, LLC | 512,500 | $11,798,000 | 5.98% |
Bain Capital Life Sciences Investors, LLC | 2,122,415 | $48,858,000 | 4.55% |
BVF INC/IL | 1,691,834 | $38,946,000 | 2.12% |
Redmile Group, LLC | 3,330,999 | $76,680,000 | 1.41% |
EMERALD ADVISERS, LLC | 891,761 | $20,528,000 | 0.84% |
EMERALD MUTUAL FUND ADVISERS TRUST | 823,989 | $18,968,000 | 0.84% |
Penn Mutual Asset Management, LLC | 15,877 | $365,000 | 0.52% |
EAM Global Investors LLC | 54,274 | $1,249,000 | 0.46% |
Artal Group S.A. | 700,000 | $16,114,000 | 0.39% |